Specific and Dose–Dependent Enzyme Induction by Omeprazole in Human Beings
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Omeprazole induces hepatic cytochrome P–4501A2. In a previous study this effect was shown to be significant in vivo in 6 poor metabolizers, including 1 intermediate metabolizer, but not in 12 extensive metabolizers of S –mephenytoin after 7 days of treatment with 40 mg/day omeprazole. In this study, the specificity of the inducing potential of omeprazole was investigated in these volunteers. Furthermore, in eight of the extensive metabolizers the dose–dependence of cytochrome P–450 1A2 induction was evaluated. Cytochrome P–450 1A2 activity was monitored by means of the 13C–[ N3 –methyl]caffeine breath test and by means of plasma caffeine clearance before omeprazole treatment with 120 mg/day, on the seventh day of dosage and after a 7–day washout. Omeprazole plasma concentration was measured. Results were compared with those after 40 mg. γ–Glutamyltransferase activity in serum, as well as urinary excretion of d–glucaric acid and 6β–hydroxycortisol, were measured on the same study days in all study groups (n = 26). In the eight extensive metabolizers the breath test indicated a dose–dependent increase of cytochrome P–450 1A2 activity of 8.5% ± 15.0% (40 mg, mean ± SD, NS) and 27.2% ± 16.5% (120 mg, p = 0.002). Caffeine clearance was increased by 31.6% ± 20.7% (p < 0.001) with the higher dose. None of the study groups exhibited a significant increase of γ–glutamyltransferase activity or urinary excretion of d–glucaric acid or 6β–hydroxycortisol. This was in contrast to the phenobarbital–type induction observed after treatment with antiepileptic drugs. Induction by omeprazole seems to be restricted to cytochrome P–450 1A enzymes. Thus cytochrome P–450 1A2 induction is not clinically relevant with common therapeutic doses in EMs but might be of relevance after extraordinarily high doses or in poor metabolizers of S –mephenytoin. (Hepatology 1994;20:1204-1212).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ged, C., Rouillon, J., Pichard, L., Combalbert, J., Bressot, N., Bories, P., Michel, H., Beaune, P., & Maurel, P. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03516.x · Cited by 333
BURSTEIN, S., & KLAIBER, E. L. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-2-293 · Cited by 82
Cited by
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
Desta, Z., Zhao, X., Shin, J.-G., & Flockhart, D. A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241120-00002 · Cited by 942
Inhibition and Induction of Cytochrome P450 and the Clinical Implications
Lin, J. H., & Lu, A. Y. H. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835050-00003 · Cited by 829
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Inhibition and induction of CYP enzymes in humans: an update
Hakkola, J., Hukkanen, J., Turpeinen, M., & Pelkonen, O. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02936-7 · Cited by 418
Inhibition and induction of human cytochrome P450 (CYP) enzymes
PELKONEN, O., MÄEENPÄEÄ, J., TAAVITSAINEN, P., RAUTIO, A., & RAUNIO, H. (1998) · Xenobiotica · doi:10.1080/004982598238886 · Cited by 358
Metadata
- Authors
- Rost, K. L., Brösicke, H., Heinemeyer, G., & Roots, I.
- Venue
- Hepatology
- Published
- 1994-11
- Volume
- 20
- Issue
- 5
- Pages
- 1204-1212
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2100938736
- Cited by
- 85
- References
- 2
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Specific and Dose–Dependent Enzyme Induction by Omeprazole in Human Beings. https://app.cochat.ai/papers/10.1002/hep.1840200516
- The paper
- Rost, K. L., Brösicke, H., Heinemeyer, G., & Roots, I. (1994). Specific and Dose–Dependent Enzyme Induction by Omeprazole in Human Beings. Hepatology. https://doi.org/10.1002/hep.1840200516
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.